Net Loss Per Share

6 Months Ended

Jun. 30, 2024

Net Loss Per Share

Net Loss Per Share

12. Net Loss Per Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the periods. Fully diluted net loss per common share is computed using the weighted average number of common and dilutive common equivalent shares outstanding during the periods. Common equivalent shares consist of stock options, warrants, and unvested restricted stock that are computed using the treasury stock method.

For the three and six months ended June 30, 2024 and 2023, all of the Company’s common stock options, unvested restricted stock units and warrants are anti-dilutive and therefore have been excluded from the diluted calculation.

The following table reconciles net loss to net loss attributable to Scorpius Holdings, Inc.:

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Net loss from continuing operations	$	(9,283,709)	$	(11,576,196)	$	(13,941,397)	$	(24,049,194)
Net loss from discontinued operations		—		(2,385,506)		—		(2,807,643)
Net loss		(9,283,709)		(13,961,702)		(13,941,397)		(26,856,837)
Net loss-non-controlling interest		(408,861)		(69,686)		(649,000)		(180,175)
Net loss attributable to Scorpius Holdings, Inc.	$	(8,874,848)	$	(13,892,016)	$	(13,292,397)	$	(26,676,662)
Weighted-average common shares outstanding, basic and diluted		328,979		130,237		234,936		130,047
Net loss per share, basic and diluted - continuing operations	$	(26.98)	$	(88.35)	$	(56.58)	$	(183.54)
Net loss per share, basic and diluted - discontinued operations		—		(18.32)		—		(21.59)
Net loss per common share attributable to Scorpius Holdings, Inc., basic and diluted	$	(26.98)	$	(106.67)	$	(56.58)	$	(205.13)

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share during the three and six months ended June 30, 2024 and 2023 due to their anti-dilutive effect:

	For the Six Months Ended
	2024	2023
Outstanding stock options	30,938	34,290
Restricted stock subject to forfeiture and restricted stock units	—	1,550
Outstanding common stock warrants	299,112	1,569